Advisor, Corporate Finance

Joe Boystak

Joe is an Advisor of Corporate Finance at Health2047 Inc. He has been CEO at Brightwaters Capital for more than 10 years. Joe is also Managing Partner at Health2047 Capital Partners. During his 25-year career in healthcare investment banking on Wall Street, Joe became the founding Managing Director of Life Science Investment Banking at Jeffries. He is a seasoned technology and healthcare advisor with expertise in investment banking, venture capital, and private equity. Joe has co-founded and helped launch companies in the therapeutic, molecular diagnostic, medical technology, information technology and artificial intelligence sectors out of top-tier academic medical centers including UCLA, Johns Hopkins, Harvard and Memorial Sloan Kettering. He started his career at American Medical International, Inc., a global health services company, in corporate development. Joe serves or has served on numerous corporate and non-profit boards, some of which include PAIGE LLC, Bruin Biometrics LLC, Exosome Diagnostics, Inc., SoCalBio, Johns Hopkins Bloomberg School of Public Health Advisory Board and chaired the Committee on Innovation and Commercialization, and UCLA’s Foundation Board of Governors. He frequently lectures at industry and academic events including the Milken Institute’s Global Conference. He is a registered representative with FINRA and holds Series 7 and Series 63 securities licenses. Joe earned his Master of Health Science from Johns Hopkins Bloomberg School of Public Health and his B.A. from Boston University.